Although the somatic mutations sometimes overlap with those in hereditary NF2 (Figure 2), there are no published papers documenting an increased risk of cancer in neurofibromatosis patients; individuals with hereditary NF2 do develop schwannomas, ependymomas, and meningiomas. The gene discussed is NF2; the disease is cancer.